All device, diagnostic, and digital startups are encouraged to apply to MedTech Innovator at https://medtechinnovator.org/apply. Additionally, the following list highlights technologies identified as specifically of strategic interest via our medtech industry survey.
Our interests are not limited to this list, but if you know a company that matches any of the below interest areas, please encourage them to apply and/or nominate them directly at https://goo.gl/forms/m2QXJfJgfPpxKNUx2.
Disrupts an existing drug market with an unmet need
Minimally invasive surgical tools
Innovative safety mechanisms
Automated cell culture equipment and systems
REMOTE PATIENT MONITORING AND CLINICAL STUDIES
Measure relevant biometric & behavior parameters
With/without clinical decision support
ADDITIONAL INTEREST AREAS
U.S. ARMY MEDICAL RESEARCH AND MATERIAL COMMAND
MedTech Innovator is sourcing opportunities in partnership with US military for a military pitch event to be held in March. The following list highlights technologies identified as specifically of interest by the US Military for this event. If you know a company that matches any of these interest areas, then please encourage them to apply at https://medtechinnovator.org/apply.
|MEDICAL INFORMATICS, TELE-HEALTH, MODELING, AND SIMULATIONS:||COMBAT CASUALTY CARE:|
|COMBAT TRAUMA AND ACUTE REHABILITATION:||MILITARY OPERATIONAL MEDICINE RESEARCH PROGRAM:|
BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY
MedTech Innovator was selected by BARDA to accelerate the development and availability of transformative technologies and approaches to protect Americans from health security threats. If you know a company that matches the interests below, please encourage them to email email@example.com and apply at https://www.drive.hhs.gov/partner.html?id=applyNow and reference MedTech Innovator as the source of the application.
Sepsis is one of the country’s most urgent systemic health threats. Each year, more than 1.5 million people in the U.S. get sepsis. Sepsis kills a quarter-million Americans each year. Sepsis can occur when a trauma or an infection – often caused by a superbug or drug-resistant bacteria in the skin, lungs or kidney (urinary tract) – triggers a chain reaction throughout the body. Without timely recognition and treatment, it can rapidly cause tissue damage, organ failure, and death. One in three patients who die in a hospital have sepsis. Read more about sepsis.
DRIVe is seeking bold solutions to solve sepsis. These include innovations focused on:
Too often, people do not receive adequate and timely treatment for infectious diseases like influenza. We either do not seek care, or do so many days late, leading to severe illness, and transmission of infectious agents within the household, at the workplace. Early Notification to Act, Control, and Treat (ENACT) will disrupt the traditional clinical care paradigm of healthcare outside of the home (within a physician’s office, urgent care center, or hospital). It will rapidly leverage the power of transformational technologies to empower individuals to be aware of their own health status and to take action.
DRIVe seeks solutions that: